US 11324811
Optimization of enzyme replacement therapy for treatment of homocystinuria
granted A61KA61K38/51A61K47/60
Quick answer
US patent 11324811 (Optimization of enzyme replacement therapy for treatment of homocystinuria) held by The Regents of the University of Colorado, a Body Corporate expires Mon May 05 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue May 10 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 05 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K38/51, A61K47/60